Related Experiment Videos
Rituximab in stem cell transplantation for aggressive lymphoma
Steven M Horwitz1, Sandra J Horning
1Oncology and Bone Marrow Transplantation, Stanford University, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.
Current Hematology Reports
|June 26, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Extranodal natural killer/T-cell lymphoma: From fatal to curable.
CA: a cancer journal for clinicians·2026
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
Current hematology reports·2006
The treatment of immune thrombocytopenic purpura in children.
Current hematology reports·2006
Volume-reduced platelet concentrates.
Current hematology reports·2006
Platelet transfusions in infants with necrotizing enterocolitis.
Current hematology reports·2006
Methods for counting platelets in severe thrombocytopenia.
Current hematology reports·2006
Flow cytometry for the diagnosis of autoimmune thrombocytopenia.
Current hematology reports·2006
Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.
Journal of psychosomatic research·2026
Alemtuzumab Induction via Intravenous vs. Subcutaneous Administration in Pediatric Kidney Transplantation.
Pediatric transplantation·2026
Integrating Deceased and Living Donation: Six-Year Outcomes of the Italian Deceased-Donor-Initiated Kidney Paired Exchange (DEC-K) Program.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026